REACTIVITY OF ANTINUCLEAR FACTORS WITH DNA-NUCLEOPROTEINS

[1] BECK JS, 1961, LANCET, V1, P1203

[2] BECK JS, 1962, LANCET, V1, P241

[3] CASALS SP, 1963, J LAB CLIN MED, V62, P625

[4] GELL PGH, 1963, CLINICAL ASPECTS IMM, P681

[5] HOLBOROW EJ, 1959, LANCET, V1, P809

[6] SERUM ANTI-NUCLEAR FACTOR AND AUTO-IMMUNITY [J]. PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1960, 53 (08): : 625 - 627

[7] HOLBOROW EJ, 1963, CLINICAL ASPECTS IMM, P681

[8] KIRBY KS, 1959, BIOCHEM J, V71, pP27

[9] KROOTH ROBERT S., 1961, SCIENCE, V134, P284, DOI 10.1126/science.134.3474.284-a

[10] LACHMANN PJ, 1961, IMMUNOLOGY, V4, P153

[1] BECK JS, 1961, LANCET, V1, P1203

[2] BECK JS, 1962, LANCET, V1, P241

[3] CASALS SP, 1963, J LAB CLIN MED, V62, P625

[4] GELL PGH, 1963, CLINICAL ASPECTS IMM, P681

[5] HOLBOROW EJ, 1959, LANCET, V1, P809

[6] SERUM ANTI-NUCLEAR FACTOR AND AUTO-IMMUNITY [J]. PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1960, 53 (08): : 625 - 627

[7] HOLBOROW EJ, 1963, CLINICAL ASPECTS IMM, P681

[8] KIRBY KS, 1959, BIOCHEM J, V71, pP27

[9] KROOTH ROBERT S., 1961, SCIENCE, V134, P284, DOI 10.1126/science.134.3474.284-a

[10] LACHMANN PJ, 1961, IMMUNOLOGY, V4, P153